‘Will soon make data of Covaxin efficacy public’
As the clamour grows for Bharat Biotech to publish the phase-III data for indigenously developed Covaxin, the company said it is committed to data transparency and will soon be making the final analysis data of the efficacy trials public.
Admin
0
6
As the clamour grows for Bharat Biotech to publish the phase-III data for indigenously developed Covaxin, the company said it is committed to data transparency and will soon be making the final analysis data of the efficacy trials public. 
